TERADYNE, INC
TEROther · Large accelerated filer · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $3.19B | $2.82B | $2.68B | $3.16B | $3.70B | $704.4M |
| Operating income | $650.1M | $593.8M | $501.1M | $831.9M | $1.20B | $928.4M |
| Net income | $554.0M | $542.4M | $448.8M | $715.5M | $1.01B | $784.1M |
| Total assets | $4.18B | $3.71B | $3.49B | $3.50B | $3.81B | $3.65B |
| Total liabilities | $1.39B | $889.4M | $960.9M | $1.05B | $1.25B | $1.44B |
| Equity | $2.80B | $2.82B | $2.53B | $2.45B | $2.56B | $2.21B |
| EPS (diluted) | $3.47 | $3.32 | $2.73 | $4.22 | $5.53 | $4.28 |
| Shares out. | 161.7M | 153.1M | 156.0M | 162.4M | 166.7M | 166.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 20.4%
- Net margin
- 17.4%
- Return on equity
- 19.8%
- Return on assets
- 13.2%
- Return on capital (ROCE)
- 21.2%
- Liabilities / assets
- 33.2%
- Debt / equity
- 0.50×
- Book value / share
- $17.29
- Revenue growth (YoY)
- 13.1%
- Net income growth (YoY)
- 2.2%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 5.05safe
- Accruals / assets
- −2.9%clean
- Beneish M-Score
- -2.14normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 7 good- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Portfolio Management LlcPassive (13G)Apr 29, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Fmr LlcPassive (13G)May 12, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Poulin Shannon JohnOfficer — President, Semiconductor Test | May 21, 2026 | Sell | 1,008 | $345.37 |
| Matz MarilynDirector | May 21, 2026 | Sell | 400 | $350.00 |
| Smith Gregory StephenOfficer — President and CEO | May 15, 2026 | Option exercise | 4,597 | $72.10 |
| Matz MarilynDirector | May 15, 2026 | Sell | 800 | $338.98 |
| Herweck PeterDirector | May 8, 2026 | Grant | 668 | $0.00 |
| Johnson MercedesDirector | May 8, 2026 | Grant | 668 | $0.00 |
| Matz MarilynDirector | May 8, 2026 | Grant | 668 | $0.00 |
| Van Kralingen Bridget ADirector | May 8, 2026 | Grant | 668 | $0.00 |
| Tufano Paul JDirector | May 8, 2026 | Grant | 668 | $0.00 |
| Sayiner NecipDirector | May 8, 2026 | Grant | 668 | $0.00 |
| Maddock Ernest EDirector | May 8, 2026 | Grant | 668 | $0.00 |
| Henry Andrew ChisholmDirector | May 8, 2026 | Grant | 668 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 6.1M | 1.6 | +13.4% |
| Apr 30, 2026 | 5.4M | 1.3 | +10.3% |
| Apr 15, 2026 | 4.9M | 1.6 | +0.6% |
| Mar 31, 2026 | 4.9M | 1.6 | -5.9% |
| Mar 13, 2026 | 5.2M | 1.4 | +12.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 11, 2026
- Results of operationsApr 29, 2026
- Results of operationsFeb 3, 2026
- Results of operationsOct 29, 2025
- Director / officer change · Regulation FD disclosureOct 28, 2025
- Director / officer changeSep 2, 2025
- Results of operationsJul 30, 2025
- Director / officer change · Regulation FD disclosureJun 26, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 144Jun 2, 2026
- 4May 26, 2026
- 4PRIMARY DOCUMENTMay 26, 2026
- 144May 22, 2026
- 144May 21, 2026
- 144May 21, 2026
- 4May 19, 2026
- 4PRIMARY DOCUMENTMay 19, 2026
- 144May 15, 2026
- 144May 15, 2026
- 4PRIMARY DOCUMENTMay 12, 2026
- 4PRIMARY DOCUMENTMay 12, 2026
- 4PRIMARY DOCUMENTMay 12, 2026
- 4PRIMARY DOCUMENTMay 12, 2026
- 4PRIMARY DOCUMENTMay 12, 2026
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.